Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 58

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 58
---
 Subscription Agreement and the form of Registration Rights Agreement related to the PIPE Financing.

In connection with the PIPE Financing, we granted the PIPE Investors certain resale registration rights pursuant to the terms of the Subscription Agreement and
form of Registration Rights Agreement, which will be entered into at the closing of the PIPE Financing. In addition to the registration rights, the PIPE Investors may be entitled to receive liquidated damages upon the occurrence, or failure to
occur, of a number of events relating to the filing, effectiveness and maintenance of effectiveness of a registration statement related to the common stock and Pre-Funded Warrants sold in the PIPE Financing. The liquidated damages will be payable
upon the occurrence, or failure to occur, of each of those events and each monthly anniversary thereof until cured. The amount of liquidated damages payable per monthly period would be equal to 1% of the aggregate purchase price paid by the
purchaser, provided, however, the maximum aggregate liquidated damages payable to the purchaser would be 5% of the aggregate amount paid by such purchaser for the purchaser of such securities in the PIPE Financing.

Some Aadi directors, executive officers and principal stockholders have interests in the PIPE Financing that are different from yours and that may influence them to support or approve the PIPE Financing without regard to your interests.

Certain directors, affiliated funds of directors, and an
executive officer of Aadi have interests in the PIPE Financing that are different from, or in addition to, the interests of Aadi stockholders generally. Certain directors,

- 39 -

affiliated funds of directors, and an executive officer of Aadi entered into the Subscription Agreement in connection with the PIPE Financing, and committed to purchase an aggregate of
4,577,000 shares of common stock and 8,333,000 Pre-Funded Warrants. The PIPE Investors include entities that are related to Casey Castelein, M.D., Anupam Dalal, M.D., Behzad Aghazadeh, Ph.D. and
Baiteng Zhao, who serve on our board of directors, as well as an executive officer for the year ended December 31, 2024, Bryan Ball.

Additionally,
it is expected that Dr. Lennon, Mr. Giacobello and Mr. Ball will continue to serve as executive officers of Aadi following the PIPE Financing and that all members of Aadi’s board of directors will continue to serve thereon following the PIPE
Financing, and that such officers and directors will continue to receive cash and other compensation